Skip to main content
. 2023 Mar 31;23:197. doi: 10.1186/s12879-023-08172-5

Table 1.

Baseline characteristics of patients

Characteristic Fluvoxamine (n = 42) Placebo (n = 43) P-value
Age 39.8 ± 14 [19–70] 37.2 ± 14.3 [18–75] 0.399
Sex
 Women 20 (47.6%) 21 (48.8%) 0.911
 Men 22 (52.4%) 22 (51.2%)
COVID-19 Vaccination
 AstraZeneca 13 (31%) 10 (23.3%) 0.769
 Sinopharm 28 (66.7%) 31 (72.1%)
 Sputnik 1 (2.4%) 1 (2.3%)
 Pastocovak 0 (0%) 1 (2.3%)
Past medical history
 Hypertension 2 (4.8%) 5 (11.6%) 0.713
 Ischemic heart disease 3 (7.1%) 2 (4.7%) 0.676
 Diabetes mellitus 2 (4.8%) 1 (2.3%) 0.616